Thursday, December 30, 2021
2:15 PM EST – Mindset Pharma Inc. : Today provided a recap of its 2021 milestones and highlights. “In 2021, we made significant progress in building our portfolio of next-generation psychedelic compounds showing improved preclinical safety and efficacy of 5-MeO-DMT and psilocybin-based therapies,” said James Lanthier, CEO of Mindset. Operational Highlights include an Expanded Patent Portfolio, an Advanced First Lead Drug Candidate Toward Clinical Trials, Effect Size & Safety Differentiation Driven by Technology Platform. Mindset Pharma Inc. (C.MSET) shares were up 0.03 cents at 0.85.
Stocks in Play: Mindset Pharma Inc., Thu, 30 Dec 2021 02:27:06 EST